China rushes to develop Moderna-style cancer vaccines amid market frenzy

scmp.com 26 Aug 香港

A group of Hong Kong-listed biotechnology companies have seen their stock prices surge in the wake of Moderna’s breakthrough cancer vaccine trial, as the Chinese companies push forward with similar vaccine programmes. The companies – from Jiangsu Hengrui Pharmaceuticals to Li Ka-shing-backed CK Life Sciences – already have a slew of cancer vaccines in development. “China is moving quickly and has

汇集自该国主要新闻编辑室。每条新闻均链接至原始来源。